Navigation Links
Predisposing factors for conversion of mild cognitive impairment to AD identified
Date:3/1/2010

Amsterdam, March 1, 2010 Mild cognitive impairment (MCI) is often considered an early symptom of Alzheimer's disease (AD). An analysis of genetic risk factors predisposing to MCI is critical for accessing individual predisposition and reliably evaluating the effectiveness of early treatment. In a groundbreaking study published in the February 2010 issue of the Journal of Alzheimer's Disease investigators successfully used artificial neural networks (ANNs) to help understand the causal relation between multiple factors and the occurrence of neurodegenerative disorders.

ANNs are computer algorithms inspired by the highly interactive processing of the human brain. Like the brain, they can recognize patterns, manage data and learn. This novel form of data analysis can accurately detect complex relationships between independent and dependent variables. When exposed to a complex data set, they recognize the underlying mechanisms of time series and outcomes, thus identifying complex interactions among input data, and recognising hidden relations that are not apparent using traditional statistical methods.

Using ANNs a team of researchers lead by Massimo Tabaton, University of Genova, Italy, analyzed 22 variables, which are recognized risk factors of AD in patients with MCI. Analysis indicated that hyperglycemia, female gender and the apoE4 genotype, in this order, were the biological variables with the highest relevance for predicting the conversion of MCI into AD within 2 years. This was followed by the scores on attentional and short memory tests.

Professor Tabaton and his colleagues commented, "This finding may have implications in clinical practice, as genetic variations can be easily examined and combined with other biomarkers, personal history and environmental exposure to establish a tailored risk profile. In fact, adjustment for the baseline risk, which should be more accurately assessed by taking into account genetic variations, would be required to estimate the utility of therapeutic and preventive intervention."

"This work highlights the biological and genetic basis for the conversion of benign forgetfulness to AD and directs our efforts to new therapeutic avenues," agree George Perry and Mark A. Smith, Editors-in-Chief of the Journal of Alzheimer's Disease.


'/>"/>

Contact: Esther Mateike
e.mateike@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Study, meta-analysis examine factors associated with death from heatstroke
3. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
4. Severe heart defect likely caused by genetic factors
5. Aggressively Treating Cardiac Risk Factors May Reverse Ischemia
6. Largest Study Ever to Investigate Risk Factors of Autism and Other Developmental Disabilities Will Begin Enrolling Families in Bay Area and Across U.S.
7. Age, burden, divorce and heavy tea consumption are significant risk factors for erosive esophagitis
8. Cell Addiction to Growth Factors May Help Spur Cancers
9. Study examines factors associated with survival in advanced laryngeal cancer
10. Cardiovascular disease death rates decline, but risk factors still exact heavy toll
11. Human factors researchers test voting systems for seniors that can improve voting accuracy and speed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Melbourne, FLA (PRWEB) , ... February 09, 2016 ... ... the team at Clevens Face and Body Specialists are delighted to welcome a ... Certified ARNP joins Clevens Face and Body Specialists as a nurse practitioner performing ...
(Date:2/9/2016)... ... February 09, 2016 , ... Center ... who are diagnosed with autism spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid ... applied behavior analysis (ABA) is key to providing effective treatment for individuals with ...
(Date:2/9/2016)... ... February 09, 2016 , ... Cirracore Enterprise Cloud, today announced ... to the cloud. Cirracore provides a secure VMware® vCloud Air based cloud ... Transformation Solutions (TSL Partners) provides a full range of services from planning, ...
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain Research ... playing field .” , As corresponding author Dr John F. Peppin says “Terminology matters, ... diagnose our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are ...
(Date:2/9/2016)... ... February 09, 2016 , ... IsoComforter, Inc., ... introduction of the newly designed, innovative shoulder wrap. The newly designed shoulder ... for the injured arm and shoulder to promote faster healing. It is highly ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
(Date:2/9/2016)... -- Amarantus BioScience Holdings, Inc. (OTCQB: ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference which ... New York City . The Company,s presentation will ... pm by Gerald E. Commissiong , President & ...
(Date:2/9/2016)... "Global Blood Monitoring & Cardiac Monitoring Devices Market Assessment & Forecast: ... global market for blood monitoring & cardiac monitoring devices was valued ... US$ 24,830.1 million by 2019 at a CAGR of 6.8% from ... Europe , Asia-Pacific , ... Africa . The three major factors determining growth of ...
Breaking Medicine Technology: